EDSA READ THE FULL EDSA RESEARCH REPORT Business Update Gearing Up for Phase 2 Vitiligo Trial in Mid-2026 Edesa Biotech, Inc.

The global medical humidifier market is projected to experience a growth rate of approximately 6% over the next five years.

A multicenter study across Japan found that ICU patients receiving more intensive rehabilitation regained independence faster ...

Technological Advancements: Continuous advancements in ventilator technology, such as the development of portable and user-friendly devices, are driving market growth. Manufacturers are focusing on ...

Lungpacer Medical announced today that physicians performed the first commercial procedures using its FDA-cleared AeroPace ...

Lungpacer Medical, a leader in innovative respiratory care neurostimulation technologies, today announced that physicians at one of the nation’s largest healthcare providers ...

Lungpacer Medical, a leader in innovative respiratory care neurostimulation technologies, today announced that physicians at one of the nation’s largest healthcare providers and top hospitals has ...

The VentO₂ux ventilator supports critically ill respiratory patients and features a compact, lightweight design.

Among critically ill adults receiving invasive mechanical ventilation, early use of an automated closed-loop ventilation system did ...

Vapotherm, Inc., a leader in advanced respiratory support technologies, today announced a strategic partnership with Flight Medical Innovations Ltd. to bring the newly cleared VentO2ux(TM) ventilator ...

According to an economic analysis of the REVISE trial, IV pantoprazole, previously proven to reduce clinically significant ...